Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SOPHiA GENETICS SA SOPH

Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and... see more

Recent & Breaking News (NDAQ:SOPH)

SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India

PR Newswire January 14, 2024

SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire January 10, 2024

Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data Analytics

PR Newswire January 8, 2024

Hôpital Saint-Louis Implements SOPHiA DDM(TM) Platform to Further Research of Myeloid Disorders

PR Newswire December 21, 2023

SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference

GlobeNewswire December 14, 2023

SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy Offerings

PR Newswire December 7, 2023

SOPHiA GENETICS Announces Expansion of Work with CHU de Nîmes

PR Newswire November 30, 2023

SOPHiA GENETICS Expands Relationship with Città della Salute e della Scienza di Torino

PR Newswire November 28, 2023

The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICS

PR Newswire November 17, 2023

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM(TM)

PR Newswire November 7, 2023

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023

GlobeNewswire November 7, 2023

SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023

GlobeNewswire October 24, 2023

SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care

PR Newswire October 18, 2023

Shaare Zedek Medical Center Uses SOPHiA GENETICS to Advance Research of Myeloid Disorders

PR Newswire September 29, 2023

Laboratorio Curie Expands Relationship with SOPHiA GENETICS

PR Newswire September 13, 2023

SOPHiA GENETICS Announces the IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) is Live on the SOPHiA DDM(TM) Platform

PR Newswire September 7, 2023

CHU Bordeaux is live on SOPHiA GENETICS

PR Newswire August 30, 2023

SOPHiA GENETICS Expands Relationship with Gustave Roussy

PR Newswire August 22, 2023

A.O.U. San Giovanni di Dio Ruggi d'Aragona Expands Usage of SOPHiA GENETICS DDM(TM) Platform

PR Newswire August 17, 2023

SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2023

GlobeNewswire August 8, 2023